BioDelivery Sciences International, Inc. at the Milano Tech 2004
Technology Partnering Conference
Milano, Italy - May 19-20, 2004
NEWARK, N.J., May 12 /PRNewswire-FirstCall/ -- BioDelivery Sciences
International, Inc. announced today their participation in the Milano TECH
2004, Technology Partnering Conference to be held May 19-20, 2004 in Milano,
Italy. Dr Raphael J. Mannino, BDSI's Executive Vice President and Chief
Scientific Officer, will give a presentation on nanocochleate technology and
its applications. "These investor conferences have been very successful for
BioDelivery Sciences International Inc. in the past and provide great
partnering opportunities," said Dr. Mannino.
For more information about MilanoTech 2004, visit http://www.milanogroup.com/ BioDelivery Sciences International, Inc. is a biotechnology company that is
developing and seeking to commercialize a patented delivery technology designed
for a potentially broad base of pharmaceuticals, vaccines, over-the-counter
drugs, and nutraceuticals and, through its subsidiary, Bioral Nutrient
Delivery, LLC, micronutrients in processed foods and beverages and personal
care products.
Note: Except for the historical information contained herein, this press
release contains forward-looking statements that involve risks and
uncertainties. Such statements are subject to certain factors, which may cause
the Company's results to differ. Factors that may cause such differences
include, but are not limited to, the Company's ability to accurately forecast
the demand for each of its licensed technology and products associated
therewith, the gross margins achieved from the sale of those products and the
expenses and other cash needs for the upcoming periods, the Company's ability
to obtain raw materials from its contract manufacturers on a timely basis if at
all, the Company's need for additional funding, uncertainties regarding the
Company's intellectual property and other research, development, marketing and
regulatory risks and certain other factors that may affect future operating
results and are detailed in the company's filings with the Securities and
Exchange Commission.
L.G. Zangani, LLC provides financial public relations service to the Company.
As such L.G. Zangani, LLC and/or its officers, agents and employees, receives
remuneration for public relations and or other services in the form of monies,
capital stock in the Company, warrants or options to purchase capital in the
Company. DATASOURCE: BioDelivery Sciences International, Inc.
CONTACT: Francis E. O'Donnell, Jr., M.D, President and CEO of BioDelivery Sciences International, Inc., +1-973-972-0015; or Leonardo Zangani of L.G. Zangani, LLC, +1-908-788-9660 Web site: http://www.biodeliverysciences.com/ http://www.milanogroup.com/
|